Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,589 | 226 | 98.4% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $64.53 | 3 | 1.4% |
| Education | $11.16 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| UCB, Inc. | $761.52 | 49 | $0 (2023) |
| Eisai Inc. | $664.57 | 32 | $0 (2024) |
| Lilly USA, LLC | $421.26 | 18 | $0 (2024) |
| GE HealthCare | $329.95 | 16 | $0 (2022) |
| EMD Serono, Inc. | $267.44 | 14 | $0 (2020) |
| ABBVIE INC. | $256.47 | 10 | $0 (2024) |
| Amneal Pharmaceuticals LLC | $228.08 | 9 | $0 (2024) |
| Alnylam Pharmaceuticals Inc. | $218.76 | 10 | $0 (2024) |
| Biogen, Inc. | $193.61 | 9 | $0 (2021) |
| E.R. Squibb & Sons, L.L.C. | $129.85 | 6 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $536.75 | 21 | Lilly USA, LLC ($157.40) |
| 2023 | $450.73 | 19 | Amneal Pharmaceuticals LLC ($122.09) |
| 2022 | $407.79 | 20 | UCB, Inc. ($113.64) |
| 2021 | $925.51 | 49 | Eisai Inc. ($158.88) |
| 2020 | $810.13 | 46 | UCB, Inc. ($230.55) |
| 2019 | $731.89 | 38 | EISAI INC. ($169.05) |
| 2018 | $560.50 | 24 | GE Healthcare ($160.16) |
| 2017 | $241.77 | 13 | EMD Serono, Inc. ($53.31) |
All Payment Transactions
230 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | Amneal Pharmaceuticals LLC | CREXONT (Drug) | Food and Beverage | In-kind items and services | $25.22 | General |
| Category: NEUROLOGY | ||||||
| 11/26/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $25.27 | General |
| Category: Neurology | ||||||
| 11/21/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $25.46 | General |
| Category: PSYCHIATRY | ||||||
| 10/08/2024 | Amneal Pharmaceuticals LLC | — | Food and Beverage | In-kind items and services | $24.76 | General |
| 10/07/2024 | Lilly USA, LLC | KISUNLA (Drug) | Food and Beverage | In-kind items and services | $25.55 | General |
| Category: Neuroscience | ||||||
| 10/01/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $23.67 | General |
| Category: PSYCHIATRY | ||||||
| 08/26/2024 | Lilly USA, LLC | KISUNLA (Drug) | Food and Beverage | In-kind items and services | $26.57 | General |
| Category: Neuroscience | ||||||
| 08/12/2024 | Lilly USA, LLC | KISUNLA (Drug) | Food and Beverage | In-kind items and services | $27.05 | General |
| Category: Neuroscience | ||||||
| 05/30/2024 | Amneal Pharmaceuticals LLC | RYTARY (Drug) | Food and Beverage | In-kind items and services | $28.74 | General |
| Category: NEUROLOGY | ||||||
| 05/02/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $23.56 | General |
| Category: Neurology | ||||||
| 04/22/2024 | Lilly USA, LLC | AMYVID (Drug) | Food and Beverage | In-kind items and services | $16.90 | General |
| Category: Neuroscience | ||||||
| 04/18/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $23.80 | General |
| Category: Central Nervous System | ||||||
| 03/28/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $30.80 | General |
| Category: NEUROSCIENCE | ||||||
| 03/14/2024 | Alnylam Pharmaceuticals Inc. | AMVUTTRA (Drug) | Food and Beverage | In-kind items and services | $20.36 | General |
| Category: Genetic Disease | ||||||
| 03/12/2024 | Lilly USA, LLC | AMYVID (Drug) | Food and Beverage | In-kind items and services | $30.00 | General |
| Category: Neuroscience | ||||||
| 02/29/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $34.65 | General |
| Category: NEUROSCIENCE | ||||||
| 02/20/2024 | Lilly USA, LLC | AMYVID (Drug) | Food and Beverage | In-kind items and services | $31.33 | General |
| Category: Neuroscience | ||||||
| 02/06/2024 | Amneal Pharmaceuticals LLC | RYTARY (Drug) | Food and Beverage | In-kind items and services | $27.27 | General |
| Category: NEUROLOGY | ||||||
| 02/05/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $15.80 | General |
| Category: Neurology | ||||||
| 02/01/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $30.28 | General |
| Category: NEUROSCIENCE | ||||||
| 01/16/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $19.71 | General |
| Category: Neurology | ||||||
| 12/19/2023 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | Cash or cash equivalent | $21.84 | General |
| Category: Neurology | ||||||
| 12/12/2023 | Lilly USA, LLC | AMYVID (Drug) | Food and Beverage | In-kind items and services | $26.50 | General |
| Category: Neuroscience | ||||||
| 11/20/2023 | Amneal Pharmaceuticals LLC | RYTARY (Drug) | Food and Beverage | In-kind items and services | $25.89 | General |
| Category: NEUROLOGY | ||||||
| 11/14/2023 | Lilly USA, LLC | AMYVID (Drug) | Food and Beverage | In-kind items and services | $25.02 | General |
| Category: Neuroscience | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 2,285 | 3,921 | $475,588 | $359,193 |
| 2022 | 15 | 2,688 | 4,444 | $519,046 | $405,419 |
| 2021 | 15 | 2,653 | 4,956 | $551,813 | $430,288 |
| 2020 | 12 | 2,486 | 4,820 | $547,650 | $422,426 |
All Medicare Procedures & Services
58 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 476 | 1,517 | $113,775 | $89,103 | 78.3% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 531 | 554 | $110,800 | $86,794 | 78.3% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 593 | 864 | $86,400 | $67,730 | 78.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 172 | 414 | $49,820 | $35,327 | 70.9% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 200 | 212 | $31,800 | $24,931 | 78.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 90 | 90 | $16,220 | $12,225 | 75.4% |
| 99306 | Initial nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Facility | 2023 | 46 | 49 | $11,037 | $8,091 | 73.3% |
| 95819 | Measurement of brain wave activity (eeg), awake and asleep | Office | 2023 | 15 | 15 | $8,681 | $6,377 | 73.5% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2023 | 29 | 67 | $10,050 | $6,034 | 60.0% |
| 95910 | Nerve conduction, 7-8 studies | Office | 2023 | 29 | 34 | $6,800 | $5,331 | 78.4% |
| 93886 | Complete ultrasound of within the brain blood flow | Office | 2023 | 19 | 19 | $5,700 | $4,038 | 70.8% |
| 95957 | Measurement of brain wave activity (eeg), digital analysis | Office | 2023 | 15 | 15 | $4,500 | $3,528 | 78.4% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 21 | 21 | $7,350 | $3,080 | 41.9% |
| 93890 | Ultrasound of within the brain blood flow following medication | Office | 2023 | 13 | 13 | $4,675 | $2,740 | 58.6% |
| 93892 | Ultrasound of within the brain blood flow for blood clots | Office | 2023 | 14 | 14 | $5,676 | $2,170 | 38.2% |
| 99304 | Initial nursing facility care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 22 | 23 | $2,304 | $1,693 | 73.5% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 598 | 1,805 | $135,380 | $108,080 | 79.8% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 610 | 659 | $131,800 | $105,106 | 79.7% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 716 | 984 | $98,400 | $79,096 | 80.4% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 329 | 341 | $51,150 | $40,759 | 79.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 166 | 353 | $42,640 | $31,961 | 75.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 89 | 89 | $16,020 | $12,080 | 75.4% |
| 99306 | Initial nursing facility visit per day, typically 45 minutes | Facility | 2022 | 43 | 46 | $9,465 | $7,142 | 75.5% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2022 | 24 | 48 | $7,200 | $4,737 | 65.8% |
| 95910 | Nerve conduction, 7-8 studies | Office | 2022 | 24 | 26 | $5,200 | $4,174 | 80.3% |
About Leonard Pace
Leonard Pace is a Physical Medicine & Rehabilitation healthcare provider based in Brooklyn, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/09/2006. The National Provider Identifier (NPI) number assigned to this provider is 1639110620.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Leonard Pace has received a total of $4,665 in payments from pharmaceutical and medical device companies, with $536.75 received in 2024. These payments were reported across 230 transactions from 34 companies. The most common payment nature is "Food and Beverage" ($4,589).
As a Medicare-enrolled provider, Pace has provided services to 10,112 Medicare beneficiaries, totaling 18,141 services with total Medicare billing of $1.6M. Data is available for 4 years (2020–2023), covering 58 distinct procedure/service records.
Practice Information
- Specialty Physical Medicine & Rehabilitation
- Other Specialties Neurology
- Location Brooklyn, NY
- Active Since 06/09/2006
- Last Updated 09/11/2025
- Taxonomy Code 208100000X
- Entity Type Individual
- NPI Number 1639110620
Products in Payments
- Fycompa (Drug) $511.54
- Briviact (Drug) $406.22
- Vimpat (Drug) $355.30
- AMYVID (Drug) $201.59
- RYTARY (Drug) $178.10
- QULIPTA (Drug) $176.97
- ONPATTRO (Drug) $174.65
- ZEPOSIA (Drug) $170.90
- Leqembi (Drug) $153.03
- EMGALITY (Drug) $140.50
- Rebif (Biological) $126.55
- ACE (Device) $113.08
- Mavenclad (Drug) $104.24
- Aimovig (Biological) $80.72
- GOCOVRI (Drug) $79.87
- KISUNLA (Drug) $79.17
- ADUHELM (Biological) $66.48
- INBRIJA (Drug) $64.53
- REXULTI (Drug) $63.38
- Dhivy (Drug) $54.82
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physical Medicine & Rehabilitation Doctors in Brooklyn
Mila Mogilevsky, Do, DO
Physical Medicine & Rehabilitation — Payments: $11,219
Viktor Gribenko, Md, MD
Physical Medicine & Rehabilitation — Payments: $6,751
Dr. Shady Hassan, M.d, M.D
Physical Medicine & Rehabilitation — Payments: $4,709
Nanwai Pak, M.d, M.D
Physical Medicine & Rehabilitation — Payments: $4,549
Dr. Dmitriy Dvoskin, M.d, M.D
Physical Medicine & Rehabilitation — Payments: $4,106
Steven Horowitz, Md, MD
Physical Medicine & Rehabilitation — Payments: $3,541